Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
---|
10/11/2001 | WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
10/11/2001 | WO2001074369A1 Divided dose therapies with vascular damaging activity |
10/11/2001 | WO2001074368A1 Combination therapies with vascular damaging activity |
10/11/2001 | WO2001074341A2 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant |
10/11/2001 | CA2404592A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
10/11/2001 | CA2402539A1 Combination therapies with vascular damaging activity |
10/11/2001 | CA2402078A1 Divided dose therapies with vascular damaging activity |
10/11/2001 | CA2368966A1 New derivatives and analogues of galanthamine |
10/10/2001 | EP1140941A1 Nitrogen containing heterobicycles as factor xa inhibitors |
10/10/2001 | EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
10/10/2001 | EP1140913A1 Thiourea inhibitors of herpes viruses |
10/10/2001 | EP1140291A1 Combination chemotherapy comprising a mitotic inhibitor and a mek inhibitor |
10/10/2001 | EP1140189A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
10/10/2001 | EP1140187A1 Combinations for cardiovascular indications |
10/10/2001 | EP1140145A2 Novel exendin agonist formulations and methods of administration thereof |
10/10/2001 | EP1140124A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
10/10/2001 | EP1140115A2 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
10/10/2001 | EP1140102A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
10/04/2001 | EP1137644A1 Benzofuran derivatives, their preparation and use |
10/04/2001 | EP1137642A1 Bis-sulfonamides |
10/03/2001 | CN1315855A Immediate release tablet |
09/27/2001 | WO2001070736A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
09/27/2001 | US20010024664 Alzheimer's diseases; central nervous system disorders; antiinflammatory agent; solvent extraction from plants |
09/26/2001 | EP1135391A1 Novel triazolo(4,5-d)pyrimidine compounds |
09/26/2001 | EP1135381A1 Eletriptan hydrobromide monohydrate |
09/19/2001 | EP1133477A1 Substituted benzimidazoles and their use as parp inhibitors |
09/18/2001 | US6291458 Morpholinobenzamide salts |
09/13/2001 | WO2001030759A3 Sodium-hydrogen exchanger type 1 inhibitor crystals |
09/13/2001 | WO2001028992A3 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
09/12/2001 | EP1131301A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
09/12/2001 | CN1312724A TNF-drvived peptides of use in treating oedema |
09/07/2001 | WO2001064672A1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs |
09/07/2001 | WO2001064229A1 A medicine for treating obesity and the method of producing thereof |
09/06/2001 | US20010020016 Formulation |
09/05/2001 | EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
09/04/2001 | US6284272 Pharmaceutical compositions containing an effervescent acid-base couple |
08/30/2001 | WO2001062801A2 Humanized antibodies that sequester amyloid beta peptide |
08/29/2001 | EP1126823A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
08/29/2001 | CN1310620A Use of glucose uptake enhancer for reducing apoptosis |
08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
08/22/2001 | EP1125585A1 Remedies for immunological diseases |
08/22/2001 | EP1124828A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
08/16/2001 | US20010014689 Nervous system disorders |
08/15/2001 | CN1307867A Mizoribine tablet with improved color |
08/09/2001 | WO2001057033A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
08/09/2001 | WO2001057032A1 C10 ester substituted taxanes as antitumor agents |
08/09/2001 | WO2001057031A1 C10 carbonate substituted taxanes as antitumor agents |
08/09/2001 | WO2001057030A1 C7 carbonate substituted taxanes as antitumor agents |
08/09/2001 | WO2001057029A1 C7 heterosubstituted acetate taxanes as antitumor agents |
08/09/2001 | WO2001057028A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
08/09/2001 | WO2001056583A1 Medicine containing anemonin as effective component for treating aseptic inflammation |
08/09/2001 | WO2001056578A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs) |
08/09/2001 | WO2001056570A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
08/09/2001 | WO2001014376A8 Novel spiro compounds |
08/09/2001 | CA2399123A1 Medicament for treating aseptic inflammations containing anemonin as effective component |
08/09/2001 | CA2396197A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs) |
08/09/2001 | CA2368541A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
08/09/2001 | CA2368540A1 C7 carbonate substituted taxanes as antitumor agents |
08/09/2001 | CA2368534A1 C7 heterosubstituted acetate taxanes as antitumor agents |
08/09/2001 | CA2368510A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
08/09/2001 | CA2368151A1 C10 carbonate substituted taxanes as antitumor agents |
08/08/2001 | EP1121112A2 Storable active substance concentrate with formoterol |
08/08/2001 | CN1306818A Medicine for treating abacterial inflammation and its extraction method |
08/02/2001 | WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
08/02/2001 | WO2001055122A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
07/26/2001 | DE10100779A1 Formulierung Formulation |
07/25/2001 | EP1117652A1 Tan-1057 derivatives |
07/19/2001 | WO2001051078A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
07/19/2001 | US20010008639 Reducing dosage; analgesics |
07/19/2001 | CA2396157A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
07/17/2001 | US6262067 Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions |
07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
07/10/2001 | WO2001051056A1 Fulvestrant formulation |
07/05/2001 | WO2001047893A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
07/05/2001 | US20010006976 Efficent, notoxic process of making new key intermediate quaternary ammonium salts and 2-oxazolylalkyl sulfide derivatives and avoids the reaction of a-haloketones with an azide followed by reducing the resulting a-aminoketone |
07/05/2001 | US20010006686 Extract; antiinflammatory agent for treatment of cyclooxygenase-2 (COX-2) conditions such as arthritis, pain from cancer; selective inhibition of COX-2 over COX-1 |
07/05/2001 | CA2394097A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
06/28/2001 | WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
06/27/2001 | EP1109537A1 Immediate release tablet |
06/26/2001 | US6253104 Method of preparing pharmaceutical Moxa extract and apparatus for electrical moxibustion using the same extract |
06/26/2001 | US6251380 Extraction of plants with methanol, dichloromethane, ethyl acetate, mixing and drying then dilution |
06/21/2001 | WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
06/21/2001 | CA2394552A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamideinhibitors of cyclin dependent kinases |
06/14/2001 | WO2001042193A1 β2-ADRENERGIC RECEPTOR AGONISTS |
06/13/2001 | EP1105152A1 Tnf-derived peptides for use in treating oedema |
06/13/2001 | EP1105144A1 Composition and method for eliminating undigested fat and reducing cholesterol in the human body |
05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
05/31/2001 | WO2001037826A1 Npyy5 antagonists |
05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
05/17/2001 | WO2001034551A1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
05/17/2001 | WO2001034189A2 Vaccines for mycoplasma bovis and methods of use |
05/17/2001 | CA2390613A1 Vaccines for mycoplasma bovis and methods of use |
05/16/2001 | EP1098657A1 Composition for treating obesity and aesthetic treatment method |
05/16/2001 | EP1098639A1 Use of a glucose uptake enhancer for reducing apoptosis |
05/15/2001 | US6231887 Drugs of pyranone derivatives |
05/10/2001 | WO2001032651A1 Quinazoline derivatives as vegf inhibitors |
05/09/2001 | EP1097937A1 N-acyl derivatives of the LL-E33288 antitumor antibiotics |
05/03/2001 | WO2001030759A2 Sodium-hydrogen exchanger type 1 inhibitor crystals |